United States
3 weeks ago

Job Overview

Pay
Not disclosed

Job description

Location:
United States
Work arrangement:
On-site

Role Summary

The Health System Medical Outcomes Science Liaison (HS MOSL) is a field-based scientific expert who serves as Alnylam's primary medical liaison within integrated delivery networks (IDNs), academic health systems, and organized healthcare entities. The HS MOSL engages formulary decision makers, C-suite healthcare leaders, clinical pharmacists, and broader clinical leaders who influence formulary and access decisions - providing balanced, evidence-based scientific and health economic information that supports informed formulary, access, and clinical pathway decisions while identifying collaborative research opportunities that advance evidence generation.

Territory includes: ND, SD, MN, MI, IN, IL, KY, MO, IA, KS, NE

Responsibilities

  • Engage and build peer-level relationships with formulary decision makers, C-suite healthcare leaders, clinical pharmacists, pharmacy directors, and key clinical leaders who influence formulary decisions within IDNs and health systems.
  • Conduct balanced, evidence-based scientific exchange to address data needs, gather insights, and communicate the clinical and economic value of Alnylam's portfolio.
  • In collaboration with the Health System Director (HSD), develop account-specific strategic plans including a detailed assessment of key influencers and decision makers.
  • Collect and share evidence gaps and insights to inform Alnylam's Value, Evidence, and Strategy (VESt) Team and advance meaningful data generation.
  • Engage health system stakeholders in evidence-based scientific and outcomes-focused dialogue, drawing on relevant clinical and health economic data to support awareness of diagnostic and treatment considerations across the disease area at the system level.
  • Identify scientific research collaboration opportunities including real-world evidence generation by leveraging internal stakeholders (Medical Affairs, Value & Access, VESt).
  • Provide HEOR and outcomes data to support formulary review processes, clinical pathway development, and health system value assessments.
  • Support regional and national IDN/healthcare systems congresses as needed.
  • Collaborate closely with MSL colleagues to ensure integrated territory-level scientific strategy across clinical and system-level stakeholders.
  • Maintain a thorough understanding of compliance requirements and applicable PhRMA Codes, OIG guidelines, FDA laws, and Alnylam's policies.
  • Apply business acumen to prioritize health system engagements that maximize scientific impact and access for patients.
  • Independently and proactively applies strategic thinking, scientific expertise, engagement excellence, integrity-driven conduct, and cross-functional collaboration within the health system driving strong execution and continuous improvement across access stakeholder engagement.

Requirements

  • Required: Advanced degree - MD, DO, PharmD, or PhD in a relevant life science discipline. HEOR fellowship, MS, MBA, or MPH is a plus.
  • 5+ years of Medical Affairs experience in pharmaceutical or biotech; prior field-based experience working directly with health systems or IDNs strongly preferred. Experience with federal health systems (VA, DoD) is a plus.
  • Demonstrated understanding of pharmacoeconomic and health outcomes research principles.
  • Solid working knowledge of US healthcare ecosystems, IDN structure, and formulary decision-making processes.
  • Strong therapeutic area knowledge; rare disease experience preferred.
  • Solid working knowledge of regulatory and compliance environment including PhRMA, OIG, and FDA guidelines.
  • Excellent written and verbal communication skills; ability to engage diverse audiences from clinical staff to C-suite system leaders.
  • Ability to travel up to 75%; must reside within assigned territory. Valid driver's license required.

About Alnylam

We are the leader in RNAi therapeutics – a revolutionary approach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possible and are just at the beginning of what’s possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, where an authentic, inclusive culture and breakthrough thinking fuel one another.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer.

Before applying, please review Alnylam's ⁠Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.

The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).

Alnylam’s robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.

  • Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers
  • U.S. Pay Range
Role:
Associate Dir, Health Systems, Medical Outcomes Science Liaison (North Central)

Company profile

Alnylam Pharmaceuticals

alnylam.com

Alnylam Pharmaceuticals is an independent biopharmaceutical company that develops RNA interference (RNAi) therapeutics, a class of medicines that treats diseases by silencing the genes that cause or contribute to them. Founded in 2002 in Cambridge, Massachusetts, by researchers including Phillip Sharp and Phillip Zamore, Alnylam saw the world's first RNAi therapeutic approved in 2018, and five more of its medicines have been approved since. The company is developing therapies for both rare and prevalent diseases and is listed on the Nasdaq.

Company Size
1,000 - 5,000 employees
Headquarters
Cambridge, Massachusetts, United States
Founded
2002
Founders
Phillip Sharp, David Bartel, Thomas Tuschl, Paul Schimmel, Phillip Zamore
Funding Stage
Public

More jobs at Alnylam Pharmaceuticals

Similar Medical Affairs - US TTR jobs at other companies